Abstract
Rotation is one of the most widely used tests in behavioural neuroscience. It is designed to detect motor turning and side biases in animals with lesions of basal ganglia circuits of the brain, and most notably following unilateral dopamine-depleting 6-OHDA lesions of the nigrostriatal bundle. When activated by stimulant or dopamine agonist drugs, rats and mice turn vigorously in circles for the duration of drug activity, yielding a reliable and easily quantifiable measure of the extent of the lesion and mechanism of drug action on the unbalanced dopamine system in the host brain. The design of automated rotometer test apparatus is discussed in detail, with advice for selecting the features most appropriate for different experimental applications. The selection of drugs, doses, time frames and testing protocols are then described, again in terms of the general principles that are readily adapted to particular experimental applications. Finally, a series of notes consider frequently asked questions related to practical issues involving drug selection, drug sensitisation, multiple testing and test spacing, and theoretical issues related to why and how does an animal rotate, and conditioning effects on the rotation response.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Dunnett SB (2005) Motor functions of the nigrostriatal dopamine system: studies of lesions and behaviour. In: Dunnett SB, Bentivoglio M, Björklund A, Hökfelt T (eds) Handbook of Chemical Neuroanatomy. Vol. 21. Dopamine. Elsevier, pp 235–299
Andén N-E, Dahlström A, Fuxe K, Larsson K (1966) Functional role of the nigro-neostriatal dopamine neurons. Acta Pharmacol. Toxicol. 24: 263–274
Ungerstedt U, Arbuthnott GW (1970) Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24: 485–493
Ungerstedt U (1971) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol. Scand. suppl. 367: 49–68
Glick SD, Jerussi TP, Fleisher LN (1976) Turning in circles: the neuropharmacology of rotation. Life Sci. 18: 889–896
Pycock CJ (1980) Turning behaviour in animals. Neuroscience 5: 461–514
Ungerstedt U, Butcher LL, Butcher SG, Andén N-E, Fuxe K (1969) Direct chemical stimulation of dopaminergic mechanisms of the neostriatum of the rat. Brain Res. 14: 461–471
Björklund A, Dunnett SB, Stenevi U, Lewis ME, Iversen SD (1980) Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 199: 307–333
Schwarz RD, Stein JW, Bernard P (1978) Rotometer for recording rotation in chemically or electrically stimulated rats. Physiol. Behav. 20: 351–354
Jerussi TP (1982) A simple, inexpensive rotometer for automatically recording the dynamics of circling behavior. Pharmacol. Biochem. Behav. 16: 353–357
Kehinde LO, Buraimoh-Igbo LA, Ude OU, Makanjuola RO (1984) Electronic rotameter for quantitative evaluation of rotational behaviour in rats after unilateral lesions of the nigrostriatal dopamine system. Med. Biol. Eng. Comput. 22: 361–366
Hudson JL, Levin DR, Hoffer BJ (1993) A 16-channel automated rotometer system for reliable measurement of turning behavior in 6-hydroxydopamine lesioned and transplanted rats. Cell Transplant. 2: 507–514
Heredia-Lopez FJ, Bata-Garcia JL, Alvarez-Cervera FJ, Gongora-Alfaro JL (2002) A novel rotometer based on a RISC microcontroller. Behav. Res. Methods Instrum. Comput. 34: 399–407
Lane EL, Dunnett SB (2010) Pretreatment with dopamine agonists influence L-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat. Behav. Brain Res. 213: 66–72
Brooks SP, Dunnett SB (2009) Tests to assess motor phenotype in mice: a user’s guide. Nat. Rev. Neurosci. 10: 519–529
Pycock C, Tarsy D, Marsden CD (1975) Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum. Psychopharmacologia 45: 211–219
Grealish S, Mattsson B, Draxler P, Björklund A (2010) Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson’s disease. Eur. J. Neurosci. 31: 2266–2278
Ungerstedt U (1976) 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome. Pharmacol. Ther. B 2: 37–40
Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. suppl. 367: 69–93
Heikkila RE, Shapiro BS, Duvoisin RC (1981) The relationship between loss of dopamine nerve terminals, striatal (3H)spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats. Brain Res. 211: 285–292
Costall B, Marsden CD, Naylor RJ, Pycock CJ (1976) The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain. Brain Res. 118: 87–113
Dunnett SB, Hernandez TD, Summerfield A, Jones GH, Arbuthnott GW (1988) Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues. Exp. Brain Res. 71: 411–424
Hefti F, Melamed E, Sahakian BJ, Wurtman RJ (1980) Circling behavior in rats with partial, unilateral nigro-striatal lesions: effects of amphetamine, apomorphine, and DOPA. Pharmacol. Biochem. Behav. 12: 185–188
Schmidt RH, Björklund A, Stenevi U, Dunnett SB, Gage FH (1983) Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiol. Scand. suppl. 522: 19–28
Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci. 13: 290–296
Kelly PH, Moore KE (1976) Mesolimbic dopaminergic neurones in the rotational model of nigrostriatal function. Nature 263: 695–696
Carli M, Evenden JL, Robbins TW (1985) Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention. Nature 313: 679–682
Koshikawa N (1994) Role of the nucleus accumbens and the striatum in the production of turning behaviour in intact rats. Rev. Neurosci. 5: 331–346
Brown VJ, Dunnett SB (1989) Comparison of adrenal and fetal nigral grafts on drug-induced rotation in rats with 6-OHDA lesions. Exp. Brain Res. 78: 214–218
Annett LE, Reading PJ, Tharumaratnam D, Abrous DN, Torres EM, Dunnett SB (1993) Conditioning versus priming of dopaminergic grafts by amphetamine. Exp. Brain Res. 93: 46–54
Carey RJ (1986) Conditioned rotational behaviour in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra. Brain Res. 365: 379–382
Acknowledgements
Our experiments in this field are supported by grants from the UK Medical Research Council, Parkinson’s UK, and the European Union Seventh Framework programme.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Dunnett, S.B., Torres, E.M. (2011). Rotation in the 6-OHDA-Lesioned Rat. In: Lane, E., Dunnett, S. (eds) Animal Models of Movement Disorders. Neuromethods, vol 61. Humana Press. https://doi.org/10.1007/978-1-61779-298-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-61779-298-4_15
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-297-7
Online ISBN: 978-1-61779-298-4
eBook Packages: Springer Protocols